Toxicity due to steroid treatment in ITP remains a concern

Henrik Frederiksen*

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review


Corticosteroids are the preferred first-line treatment in ITP in guidelines. The analyses by Wang et al. shows that hospital-registered steroid-related toxicity occurs frequently and emphasizes that exposure should be for a limited duration of time. Commentary on: Wang et al. Longitudinal evaluation of adverse events due to steroid use in primary immune thrombocytopenia: a population-based study. Br J Haematol 2024 (Online ahead of print). doi: 10.1111/bjh.19358.

Original languageEnglish
JournalBritish Journal of Haematology
Issue number5
Pages (from-to)1600-1601
Publication statusPublished - May 2024


  • corticosteroids
  • ITP
  • side effect
  • steroid treatment
  • Humans
  • Adrenal Cortex Hormones/therapeutic use
  • Purpura, Thrombocytopenic, Idiopathic/drug therapy
  • Female


Dive into the research topics of 'Toxicity due to steroid treatment in ITP remains a concern'. Together they form a unique fingerprint.

Cite this